We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.59B
AUM Growth
+$1.23B
Cap. Flow
-$770M
Cap. Flow %
-13.79%
Top 10 Hldgs %
47.55%
Holding
148
New
37
Increased
36
Reduced
28
Closed
32

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$87.6M
2
BURL icon
Burlington
BURL
+$81.6M
3
TVTX icon
Travere Therapeutics
TVTX
+$66.9M
4
HAE icon
Haemonetics
HAE
+$44.2M
5
WSM icon
Williams-Sonoma
WSM
+$43.8M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$74.6M
2
LNTH icon
Lantheus
LNTH
+$57.7M
3
AAP icon
Advance Auto Parts
AAP
+$50.2M
4
NKE icon
Nike
NKE
+$42.9M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$40.6M

Sector Composition

Rank Sector Weight
1 Healthcare 43.79%
2 Consumer Discretionary 10.03%
3 Consumer Staples 7.94%
4 Communication Services 2.1%
5 Industrials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UBER icon
26
Uber
UBER
$145B
$54.7M 0.98%
1,092,000
+732,000
+203% +$38.2M
ENR icon
27
Energizer
ENR
$1.47B
$54.7M 0.98%
1,272,000
+224,000
+21% +$10.5M
ARGX icon
28
argenx
ARGX
$55.2B
$53.6M 0.96%
178,000
+28,000
+19% +$7.96M
CLX icon
29
Clorox
CLX
$12B
$50M 0.9%
278,000
+28,000
+11% +$5.11M
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$48.5M 0.87%
500,000
-500,000
-50% -$40.6M
TH icon
31
Target Hospitality
TH
$1.43B
$46.3M 0.83%
+191,727
New +$635K
KO icon
32
Coca-Cola
KO
$383B
$44.6M 0.8%
824,000
-92,000
-10% -$5.01M
HOLX
33
DELISTED
Hologic
HOLX
$42.2M 0.75%
+632,000
New +$42.3M
HAE icon
34
Haemonetics
HAE
$3.88B
$41.6M 0.74%
+624,000
New +$44.2M
SPPI
35
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$41.4M 0.74%
11,048,000
+348,000
+3% +$1.21M
WSM icon
36
Williams-Sonoma
WSM
$27.5B
$41.1M 0.74%
+514,360
New +$43.8M
PARA
37
DELISTED
Paramount Global Class B
PARA
$40.5M 0.72%
896,000
+272,000
+44% +$11.2M
BABA icon
38
Alibaba
BABA
$276B
$40.4M 0.72%
178,000
+24,000
+16% +$5.33M
PFE icon
39
Pfizer
PFE
$143B
$40.1M 0.72%
1,024,000
-176,000
-15% -$6.84M
UNH icon
40
UnitedHealth
UNH
$382B
$40M 0.72%
100,000
-36,000
-26% -$14.4M
ASO icon
41
Academy Sports + Outdoors
ASO
$3.04B
$38.2M 0.68%
+925,326
New +$32.4M
TMO icon
42
Thermo Fisher Scientific
TMO
$214B
$37.8M 0.68%
75,000
+17,000
+29% +$8.02M
CENTA icon
43
Central Garden & Pet Co Class A
CENTA
$2.43B
$36.5M 0.65%
945,000
-45,000
-5% -$1.85M
ROST icon
44
Ross Stores
ROST
$80.8B
$36.2M 0.65%
+291,912
New +$36.4M
OCDX
45
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$35.8M 0.64%
1,672,000
-524,000
-24% -$10.7M
ORLY icon
46
O'Reilly Automotive
ORLY
$75.1B
$34.7M 0.62%
+919,275
New +$33M
TWNK
47
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$33.9M 0.61%
2,092,000
+814,000
+64% +$12.7M
BUD icon
48
AB InBev
BUD
$164B
$32.8M 0.59%
456,000
-244,000
-35% -$17.8M
LW icon
49
Lamb Weston
LW
$7.42B
$32.3M 0.58%
400,000
+122,000
+44% +$9.77M
FL
50
DELISTED
Foot Locker
FL
$31.1M 0.56%
+505,187
New +$30.5M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Armistice Capital held 148 positions worth $5.59B, up 28% from $4.36B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Armistice Capital withdrew a net $770M in Q2 2021, closing 32 positions and reducing 28 holdings. Its most notable exit was TJX Companies, an estimated $74.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Iovance Biotherapeutics worth $87.7M.

  • Armistice Capital's largest Q2 2021 buy was Iovance Biotherapeutics: 3,372,000 shares worth $87.7M.
  • Armistice Capital added most to Travere Therapeutics in Q2 2021, an estimated $66.9M increase.
  • Armistice Capital's biggest Q2 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $40.6M.
  • Armistice Capital fully exited TJX Companies in Q2 2021, selling an estimated $74.6M.
  • Armistice Capital's ten largest holdings make up 48% of its $5.59B portfolio in Q2 2021.
  • Armistice Capital opened 37 new positions and closed 32 in Q2 2021.
  • Armistice Capital's portfolio value rose 28% quarter-over-quarter to $5.59B.

Based on Armistice Capital's 13F filing for Q2 2021, filed 16 Aug 2021.